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Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant
neurological disorder caused by the expansion of a CAG repeat
encoding a polyglutamine tract. Work presented here describes
the behavioral and neuropathological course seen in mutant
SCA1 transgenic mice. Behavioral tests indicate that at 5
weeks of age mutant mice have an impaired performance on
the rotating rod in the absence of deficits in balance and
coordination. In contrast, these mutant SCA1 mice have an
increased initial exploratory behavior. Thus, expression of the
mutant SCA1 allele within cerebellar Purkinje cells has diver-
gent effects on the motor behavior of juvenile animals: a com-
promise of rotating rod performance and a simultaneous en-
hancement of initial exploratory activity. With age, these
animals develop incoordination with concomitant progressive
Purkinje neuron dendritic and somatic atrophy but relatively
little cell loss. Therefore, the eventual development of ataxia
caused by the expression of a mutant SCA1 allele is not the
result of cell death per se, but the result of cellular dysfunction
and morphological alterations that occur before neuronal
demise.
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Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant
neurological disorder characterized by ataxia and cranial motor
neuropathies. Although the basis of the ataxia probably is mul-
tifactorial, a consistent neuropathological finding is loss of Pur-
kinje cells in the cerebellar cortex and loss of neurons in the
inferior olivary nuclei (Gilman et al., 1996). Many patients also
have atrophy of the basal pontine nuclei. The reason for the
divergence of the pathological abnormalities remains unclear.
SCA1 is caused by the expansion of a CAG trinucleotide repeat
in the SCA1 gene that results in the expansion of a polyglutamine
tract within the SCA1 gene product, ataxin-1 (Orr et al., 1993).
Both transcription and translation of the expanded SCA1 allele
have been shown in SCA1 patients (Orr et al., 1993; Servadio et al.,
1995). Although the SCA1 gene is expressed ubiquitously (Banfi et
al., 1994), only a subset of neurons is affected in the disease.
Among the neuronal populations most affected are the Purkinje
cells of the cerebellar cortex (Koeppen, 1991). Developmental
expression studies performed in the mouse have detected a tran-
sient burst of Sca1 expression in the Purkinje cells of the cerebel-
lum at postnatal day 14 (P14) (Banfi et al., 1996), the time at which
the murine cerebellar cortex becomes physiologically functional.
In addition to SCA1, the expansion of an unstable CAG repeat
causes Huntington’s disease (HD) (Huntington’s Disease Collab-
orative Research Group, 1993), spinal and bulbar muscular atro-
phy (SBMA) (LaSpada et al., 1991), dentatorubral–pallidoluysian
atrophy (DRPLA) (Koide et al., 1994), Machado–Joseph disease
(MJD/SCA3) (Kawaguchi et al., 1994), spinocerebellar ataxia
type 2 (SCA2) (Imbert et al., 1996; Pulst et al., 1996; Sanpei et al.,
1996), and spinocerebellar ataxia type 6 (SCA6) (Zhuchenko et
al., 1997). These disorders share several characteristics that have
led to the suggestion of a common mechanism of pathogenesis.
Among the shared features are an autosomal dominant mode of
inheritance, except for X-linked SBMA, and genetic anticipation
on paternal transmission of an affected allele. Except for SCA6,
the size ranges of the CAG repeat tract within each gene are
similar, both on unaffected chromosomes (;6–37 repeats) as well
as on affected chromosomes (;36–121 repeats). Interestingly,
each disease has a unique and often cell-specific pattern of pa-
thology despite the common ubiquitous expression profile for
each of the associated genes.
As part of efforts to understand the role of the expanded CAG/
polyglutamine tracts in the genesis of disease, transgenic mice
displaying neurological abnormalities have been established for
SCA1 (Burright et al., 1995), MJD/SCA3 (Ikeda et al., 1996), and
HD (Mangiarini et al., 1996). Although lines of transgenic animals
that expressed a wild-type human SCA1 allele had no neurological
disease, all lines of transgenic mice that expressed the mutant form
of the SCA1 gene developed ataxia. The work presented here
describes the neurological and structural correlates of the behav-
ioral abnormalities and ataxia in the SCA1 transgenic mice.
MATERIALS AND METHODS
Transgenic mice. Transgene configuration and establishment of the
B05/1 and A02/1 lines carrying a mutant SCA1 allele with 82 CAG
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repeats and an interrupted SCA1 allele with 30 repeats, respectively,
have been described (Burright et al., 1995).
Footprint analysis.After the coating of their hind feet with a nontoxic
paint, animals were allowed to walk through a dark 40-cm-long, 9-cm-
wide, 6-cm-high tunnel. Then the footprint patterns made on the paper
lining the floor of the tunnel were scored for four step parameters. Step
Length, average distance of forward movement between alternate steps;
step length was calculated by measuring the distance of travel through
the tunnel divided by the number of steps used to traverse that distance.
Gait Width, average lateral distance between opposite left and right
steps; the gait width was determined by measuring the perpendicular
distance of a given step to a line connecting its opposite preceding and
succeeding steps. Alternation Coefficient, calculated value describing the
uniformity of step alternation; a perfect tandem alternating gait in which
all alternate steps fell exactly equidistant between the preceding and
succeeding opposite steps would have a calculated alternation coefficient
of zero. Conversely, a shuffle gait in which all alternate steps fell exactly
beside the preceding opposite steps would have a calculated value of 0.5.
The alternation coefficient was calculated by determining the mean of the
absolute values of 0.5 minus the ratio of right–left step distance to
right–right step distance for every right–left step pair taken in the tunnel.
Linear Movement, average change in angle between consecutive right–
right steps; this measurement was calculated by drawing a line perpen-
dicular to the direction of travel, starting at the first right footprint. The
angle between this perpendicular line and each subsequent right foot-
print was determined, and differences in angle were calculated between
each consecutive step pair. The absolute values of all angle differences
were summed and divided by the number of steps scored. A large linear
movement measurement would be indicative of nonlinear movement, or
weaving, through the tunnel.
Accelerating rotating rod test. The rotating rod apparatus (Accelerating
Model, Ugo Basile Biological Research Apparatus, Varese, Italy) was
used to measure the ability of mice to improve motor skill performance
with training. Only naive animals were used in this study. Mice were
placed on the rod (3 cm in diameter) for four trials per day for 4
consecutive days. Each trial lasted a maximum of 10 min, during which
time the rotating rod underwent a linear acceleration from 4 to 40 rpm
over the first 5 min of the trial and then remained at maximum speed for
the remaining 5 min. Animals were scored for their latency to fall (in
seconds) for each trial. Animals rested a minimum of 10 min between
trials to avoid fatigue and exhaustion. To investigate whether B05/1 mice
at 5 weeks of age had a preexisting motor performance deficit on the
rotating rod, we tested a separate set of untrained, naive wild-type and
B05/1 mice for their ability to remain on the rotating rod at maximum
speed (40 rpm). The results were analyzed by a two-way repeated
measures ANOVA that factors genotype, day, and trial.
Bar cross test. The bar-crossing apparatus, as designed by Gerlai et al.
(1993), tests for balance and motor coordination. The apparatus consists
of a horizontal U-shaped platform made of Formica supported on 30 cm
legs. The two parallel 30-cm-long bars of the U were wide enough (18
mm) for the mice to walk easily, whereas the piece connecting them, the
challenge bar, was also 30 cm long but only 2 mm wide. Animals were
placed on one of the wide bars and allowed to move about on the
apparatus for 10 min. After the spontaneous activity portion of the bar
cross test, animal were subjected to a forced crossing of the challenge bar.
In this task, animals were placed in the middle of the challenge bar to
force a cross attempt. A maximum of 120 sec was allowed for mice to stay
on the bar, and the latency to fall (Fall ) or cross (Cross) successfully was
measured in seconds. A Forced Cross score was calculated as follows: if
Cross was .0, then Forced Cross 5 120 2 Cross; if Fall was .0, then
Forced Cross 5 Fall 2 120. Each individual animal was assigned a value
between 1120 (most agile) and 2120 (least agile). The surface of the
apparatus was cleaned with a 70% ethanol solution and air-dried be-
tween mice. Animal performances on the bar cross apparatus were
videotaped and later manually scored for the following spontaneous
motor behaviors as defined (Crusio and Van Abeelen, 1986; Crusio et al.,
1989; Gerlai et al., 1993): Locomotion Time, duration of motor activity;
Passivity, duration of inactivity; Turns, frequency of 180° turns on the
wide bars; Cross Attempts, frequency of an animal’s placing at least two
feet onto the challenge bar and elongating its body in an attempt to cross;
Slips, frequency of an animal having one or more legs unexpectedly slip
off the wide bar or challenge bar; Sniff Up, frequency of pointing nose
upward while making movements of nasal passages; Sniff Down, fre-
quency of placing head below the platform while making movements of
nasal passages; Falls, frequency of falling off the platform; Grooming
Time, duration of wipes, licks, combs, and scratches while the animal has
assumed a sitting position with arched back; Full Cross, frequency of
successfully crossing the challenge bar; Half Cross, frequency of starting
to cross the challenge bar but turning back before reaching the other side;
Urination and Defecation, frequency of. Tests were performed on mice
between 10:00 A.M. and 4:00 P.M.
Open field test. This test was used to assess exploratory behavior and
general locomotor activity. Fifteen wild-type and 14 B05/1 mice were
analyzed. Mice were placed into the center of a 60 3 60 cm open arena
containing a 10 3 10 cm gridded floor and were allowed to move under
indirect illumination for 15 min per test for 6 consecutive days. The
surface of the arena was cleaned with a 70% ethanol solution and
air-dried between mice. On the fourth day three different objects were
placed in the arena. These objects remained in the arena on the fifth day,
but the positions of two of the objects were reversed on day 6. Activities
of animals in the arena were videotaped and later were scored for the
total number of grid crossings in each of three intervals of 5 min for each
day’s test and for the latency of the animal to initially reach the periphery
of the arena after introduction into it.
Statistical analysis. Behavioral scores were subjected to either single-
factor ANOVA or repeated measures ANOVA with the SuperANOVA
package software version 1.11 for Macintosh (Abacus Concepts, Berke-
ley, CA).
Histolog ical examination and immunohistochemistr y. Brains of trans-
genic and nontransgenic mice were immersion-fixed in 10% phosphate-
buffered formalin for a minimum of 3 d. Tissue was processed as
previously described (Burright et al., 1995). Sections were cut on a
rotary microtome (6 – 8 mm) or vibratome at (30 –50 mm). Routine
histological examination of microtome sections was done after staining
with hematoxylin and eosin. Immunohistochemical detection of calbi-
ndin (6 – 8 and 30 –50 mm sections) was performed by using mouse
monoclonal antibodies to calbindin (Sigma). Paraffin sections (6 – 8
mm) of tissues were rehydrated via xylol and graded alcohols. After
they were blocked with 10% normal horse serum for 1 hr, the sections
were incubated with mouse anti-calbindin overnight at 4°C. The sec-
tions were washed with two changes of PBS and then incubated with
the secondary antibody, horse anti-mouse IgG (Vector Laboratories,
Burlingame, CA). Sections were incubated with avidin–biotin complex
(ABC; Vector) for 30 min at room temperature, rinsed with PBS, and
then treated with DAB (Vector) to visualize substrate. Vibratome
sections were incubated in normal donkey serum for at least 1 hr at
room temperature (5% serum in 0.2 M PBS/0.3% Triton X-100; PBS-
T). After the removal of blocking solution, sections were incubated
with anti-calbindin primary antibody overnight at 4°C. The tissue was
washed with at least three changes of PBS-T and then incubated with
donkey anti-mouse (H1L)–Cy3 secondary antibody (Zymed, San
Francisco, CA) for 2 hr at room temperature or overnight at 4°C. After
being washed, the sections were mounted onto coverslips in 1.3% noble
agar, dehydrated in alcohol, and cleared in methyl salicylate.
Quantitation of Purkinje cells. Paraffin-embedded sagittally oriented 5
mm sections of mouse brains were cut at 50 mm intervals. Comparable
sections from vermis, medial hemisphere, and lateral hemisphere were
used for cell mapping and counting. Sections from 12-week-old animals
were stained with hematoxylin and eosin, whereas sections from 24-week-
old animals were immunostained with PKCg (Sigma) and counterstained
with hematoxylin to better identify the shrunken Purkinje cells. Four
B05/1 and three littermate control mice were examined at each site. A
Leitz Orthoplan microscope coordinated with Bioquant System IV (R &
M Biometrics, Nashville, TN) software was used to map the x–y coordi-
nates and to count the numbers of Purkinje cells after visual identifica-
tion. The raw coordinate data obtained by the Bioquant software were
analyzed with Macintosh Panda software and programs written espe-
cially for this purpose. Statistical significance was determined by Stu-
dent’s t test.
All behavioral tests and morphometric studies were performed and
assessed without knowledge of the genetic identity of the mice.
RESULTS
Progression of neurological alterations in SCA1
transgenic mice
Previously, we have described the generation and initial charac-
terization of transgenic animals expressing either a normal hu-
man SCA1 allele (A02 lines; 30 CAG repeats) or a mutant
human SCA1 allele (B02 lines; 82 CAG repeats) (Burright et al.,
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1995). Although the home cage behavior of A02 transgenic
animals, including A02, is indistinguishable from nontransgenic
age-matched animals, heterozygous B05 transgenic mice develop
signs of neurological abnormality, as assessed by home cage
behavior, at ;12 weeks of age. The initial abnormal neurological
signs include a gentle swaying of the head while walking and mild
incoordination. These abnormalities progressively worsen over
the following weeks until the animals become clearly ataxic when
walking. To assess further the neurological consequences of the
expression of unaffected and affected SCA1 alleles in transgenic
mice, we subjected wild-type (1/1) nontransgenic, unexpanded
SCA1 transgenic (A02/1), and expanded SCA1 transgenic
(B05/1) mice to several tests of motor skill and behavior.
Gait abnormalities in SCA1 transgenic mice
Gait parameters of transgenic mice were compared with those of
nontransgenic mice by appraising footprint patterns (Fig. 1) of
6-week-old, 12-week-old, and 1-year-old animals. The rear paws
of transgenic and nontransgenic littermates were inked, and the
mice were allowed to walk through a tunnel with a piece of paper
on its floor. The resulting footprint patterns were assessed quan-
titatively by four measurements: step length, gait width, step
alternation coefficient, and linearity of movement (Fig. 1C–F).
With these criteria the gait pattern of 6-week-old B05/1 SCA1
transgenic mice did not differ from that of their age-matched
nontransgenic littermates, whereas A02/1 animals had an in-
creased step length, a decreased gait width, and a decreased
alternation coefficient. At 12 weeks of age, when the abnormali-
ties in B05/1 home cage behavior first become apparent (Burri-
ght et al., 1995), B05/1 animals had no significant alterations in
the footprint patterns except in step length (mean for B05/1 was
21.4 vs 25.5 mm for wild-type animals; p 5 0.0094). At 1 year of
age, the footprint patterns of B05/1 animals differed dramatically
in all measured parameters from the patterns generated by
1-year-old nontransgenic littermates. Instead of walking along a
straight line with a smooth alternating gait as did wild-type
animals, 1-year-old B05/1 mice weaved from side to side while
moving through the tunnel, using a wider base and shorter steps
in a gait that lacked a normal, uniform alternating left–right step
pattern. A02/1 transgenic animal footprint patterns were indis-
tinguishable from wild-type controls at 1 year of age (Fig. 1C–F).
Performance on the accelerating rotating rod apparatus
A rotating rod apparatus was used to measure the motor perfor-
mance ability of the mice during repeated exposure to the task.
All data were collected on naive animals. In contrast to other
measures of motor performance, analysis of B05/1 mice on the
rotating rod revealed a significant deficiency in these mice at the
earliest age tested, 5 weeks. Repeated measures ANOVA per-
formed on the complete data set containing wild-type, A02/1,
and B05/1 animals confirmed a day by genotype interaction ( p 5
0.0011); post hoc analysis of wild-type versus B05/1 animals
revealed a significant day by genotype interaction ( p 5 0.0003).
Compared with age-matched nontransgenic animals, 5-week-old
B05/1 transgenic mice performed equally well on the rotating rod
during the four trials on the first day (Fig. 2A). However, on the
succeeding 3 d of trials the performance of B05/1 mice was
significantly below that of nontransgenic wild-type animals (Fig.
2A,E). Although the performance of 5-week-old B05/1 trans-
genic mice did improve significantly from day 1 to day 2, there was
no further significant improvement in performance beyond day 2
(Fig. 2A,E). This impairment by 5-week-old B05/1 mice on the
accelerating rotating rod task occurred at a time when the trans-
genic animals showed no abnormalities in home cage behavior
and did not have an impaired gait.
B05/1 transgenic animals remain capable of limited perfor-
mance improvement on the rotating rod at 12 and 19 weeks of age
(Fig. 2B,C). At 1 year of age performance on the rotating rod is
impaired dramatically. Even on the first day of trials, 1-year-old
B05/1 mice are unable to perform as well as age-matched wild-
type littermates and show no evidence of performance improve-
ment either from Trial 1 to Trial 4 on the first day or during the
remaining 3 d of trials (Fig. 2D,E). Thus the initial phase of
neurological abnormality in B05/1 animals is characterized by a
diminished capability to improve performance on the rotating
rod, whereas the later stages of disease in these mice include both
the impairment and inability to improve performance on this
motor task.
To assess whether 5-week-old B05/1 mice had a preexisting
defect in performance on the rotating rod, we tested a separate
set of wild-type (n 5 15) and B05/1 (n 5 14) animals for their
ability to remain on the rotating rod when it was spun at maxi-
mum speed (40 rpm). Before this test these animals had not been
trained on the rotating rod. Wild-type and B05/1 animals had
virtually identical means for latency to fall, 27.9 and 27.8 sec,
respectively ( p 5 0.9922). This result demonstrates that naive
B05/1 animals have the motor ability to perform as well as
wild-type mice at this test.
Mice from the transgenic line A02/1, which expresses an SCA1
transgene with an interrupted CAG repeat with 30 triplets (Bur-
right et al., 1995), also were examined for their performance on
the rotating rod. At 5 weeks of age, A02/1 mice were able to
improve their performance such that by day 4 there was no
significant difference in the performance level of A02/1 and
wild-type controls (Fig. 2A,E). However, the rate of performance
improvement seemed to be somewhat diminished in the A02/1
transgenic mice. The absolute level of performance by A02/1
animals on the rotating rod was less than that of wild-type mice
on days 2–4. However, this difference was statistically significant
only on day 2 (Fig. 2E). At 1 year of age both the level of
performance and improvement in performance of A02/1 mice
were virtually the same as those of wild-type animals.
Performance on the bar cross apparatus
As a means to assess more fully the fine motor coordination and
balance capabilities of wild-type, A02/1, and B05/1 animals,
SCA1 transgenic and nontransgenic animals were examined using
a bar cross apparatus (Gerlai et al., 1993). The test was performed
at an age when B05/1 mice first manifest deficits on the acceler-
ating rotating rod. Figure 3 presents the results obtained for
wild-type, A02/1, and B05/1 animals at 5 weeks of age on the
bar-crossing apparatus. In those activities that assess balance and
coordination, i.e., Turns, Slips, Falls, and Forced Cross, the
B05/1 transgenic animals performed equally well as their wild-
type littermates except for Slips, for which the B05/1 mice ap-
peared to have an increased frequency. However, this increase in
Slips may, in fact, be attributable to the surprising observation
that the B05/1 animals exhibited significant evidence of en-
hanced levels of spontaneous motor activity when compared with
their wild-type littermates, based on the analysis of Locomotion
Time, Passivity Time, Cross Attempts, Sniff Up, and Sniff Down.
Most notably, single-factor ANOVA of wild-type and B05/1
Locomotion Times (mean 5 67.5 and 128.7 sec, respectively; p 5
0.0009) and Passivity Times (mean 5 111.5 and 45.6 sec, respec-
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Figure 1. Analysis of footprint patterns produced by wild-type, A02/1, and B05/1 animals. Representative footprint patterns of 1-year-old wild-type
(A) and B05/1 (B) animals are shown. Footprint patterns of 6-week-old, 12-week-old, and 1-year-old wild-type, A02/1, and B05/1 animals were
quantitatively assessed for step length ( C), gait width ( D), step alternation ( E), and linearity of movement ( F ). Although A02/1 animals had slightly
increased step length and decreased gait width and alternation coefficients at 6 weeks of age, their footprint patterns were indistinguishable from those
produced by wild-type animals at 1 year. B05/1 animals showed no abnormalities in footprint patterns at 6 weeks of age. By 1 year of age, B05/1 animals
displayed a significantly shorter step length, broader gait width, higher alternation coefficient (indicating irregular step alternation), and increased linear
movement measure (indicating a nonlinear movement) as compared with similarly aged wild-type animals. *p , 0.05; **p , 0.01; ***p , 0.001. Error
bars indicate SEM and are shown when they are within the resolution of the graph.
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Figure 2. Performance of A02/1, wild-type 1/1, and B05/1 animals on an accelerating rotating rod apparatus. Five-week-old ( A), 12-week-old (B),
19-week-old (C), and 1-year-old animals (D) were tested for four trials per day for 4 consecutive days on an accelerating RotaRod. B05/1 animals showed
impaired performance improvement (A–C) or failed to improve their performance ( D) as compared with age-matched wild-type and A02/1 animals.
Repeated measures ANOVA confirmed a day by genotype interaction for 5-week-old ( p 5 0.0011), 12-week-old ( p 5 0.0355), 19-week-old ( p 5 0.0002),
and 1-year-old ( p 5 0.0001) animals. p values obtained by performing post hoc analyses comparing the daily performances of wild-type, A02/1, and
B05/1 animals are shown in E. Differences in daily performances between wild-type and A02/1 animals (wild-type vs A02/1) approach statistical
significance only on day 2 in both 5-week-old and 1-year-old animals; wild-type animals perform significantly better than B05/1 animals (wild-type vs
B05/1) on days 2–4 at 5 and 12 weeks and on days 1–4 at 19 weeks and 1 year of age. Comparison of performance on consecutive days (Day vs Day-1)
indicates that wild-type animals are able to improve their performance significantly from days 1 to 2 and from 2 to 3 at 5, 12, and 19 weeks of age, and
from day 1 to 2 at 1 year of age. A02/1 animals improve day to day in a manner similar to wild-type animals at the ages tested. Conversely, B05/1 animals
are unable to improve their performance significantly from day to day after day 2, beginning at 5 weeks of age, and are incapable of any day to day
performance improvement at 1 year of age.
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tively; p 5 0.0002) indicates that B05/1 animals exhibited signif-
icantly more spontaneous motor activity than wild-type litter-
mates (Fig. 3). Thus the observed increase in Slips for the B05/1
mice is very likely the result of these animals having significantly
higher levels of overall motor activity. In support of this conclu-
sion is the observation that the B05/1 animals are as coordinated
as the wild-type animals, as assessed by the Forced Cross test.
This test clearly shows that the B05/1 mice and the wild-type
littermates are equally agile (Fig. 3). A02/1 transgenic mice
performed similarly to B05/1 animals in all parameters scored
except in Turns and Grooming Time, in which they had signifi-
cantly lower levels of activity than wild-type animals (Fig. 3).
At 1 year of age most B05/1 mice fell repeatedly from the wide
platform of the bar cross apparatus, making it impossible to score
reliably for specific spontaneous bar-crossing behaviors. Except in
Passivity Time, in which A02/1 animals spent less time inactive
than wild-type controls ( p 5 0.0030; data not shown), there were
no significant differences between 1-year-old A02/1 and wild-
type animals in any of the bar cross behavioral parameters scored.
Performance in the open field test
To assess further the motor activity of the B05/1 transgenic mice,
we performed the open field test. This test is used to study
novelty-induced exploratory activities (Crusio et al., 1989). The
results obtained in the open field test for 6-week-old B05/1 and
wild-type littermates are presented in Figure 4. Single-factor
ANOVA indicated a significant difference between B05/1 and
wild-type animals only on the first interval of the first day of
testing (Fig. 4A; p 5 0.0230). Single-factor ANOVA also indi-
cated that B05/1 animals had a lower latency time to reach the
periphery of the open field arena on the first day of testing than
did the wild-type animals (13.5 vs 27.9 sec; Fig. 4B; p 5 0.0349).
These results suggest that B05/1 and wild-type animals differ in
their initial spontaneous motor activity when introduced into the
open field arena. This difference, however, does not persist be-
yond the first 5 min interval, at which time their levels of motor
activity are essentially equivalent. Neither the introduction nor
repositioning of objects within the open field arena induced
significant increases in motor activity of either genotype of ani-
mal (Fig. 4A).
Time course of histopathology in SCA1
transgenic mice
Examination of the cerebellum from B05/1 mice at 10, 12, 14,
and 16 d (Fig. 5A) showed normal progression of cerebellar
development. The transgenic animals could not be distinguished
from nontransgenic littermate controls at any of these times. The
earliest time examined at which there was a morphological ab-
normality was at P25. At that time some of the Purkinje cell
somata contained clear cytoplasmic vacuoles (Fig. 5B). By 8
weeks of age there was mild gliosis of the molecular layer (Fig.
5C). Some of the Purkinje cells also had cytoplasmic vacuoles.
Electron microscopic examination performed at this time re-
vealed that the vacuoles were distended cisternal structures (data
not shown). At 12 weeks of age, when abnormalities in home cage
behavior are first apparent, there was slightly increased gliosis of
the molecular layer, along with the persistence of cytoplasmic
vacuoles (Fig. 5D). At 15 weeks the histopathology became more
striking, with obvious shrinkage of the molecular layer and the
presence of heterotopic Purkinje cells well within the molecular
layer (Fig. 5E). At 6–7 months these changes were even more
evident (Fig. 5F). Vacuolar changes were present in many Pur-
kinje neurons at this time as well. In addition, there were many
Purkinje cells with more than one dendrite issuing from the cell
body.
At 1 year of age (Fig. 5G) the mutant SCA1 transgenic animals
had severe shrinkage of the cerebellar cortex, but it was difficult to
ascertain the Purkinje cell population because of the following
factors: (1) shrinkage of Purkinje cells, (2) frequent heterotopia
of Purkinje cells, and (3) loss of calbindin immunoreactivity in
surviving Purkinje cells. One-year-old A02/1 transgenic mice
expressing a wild-type human SCA1 allele with 30 CAG repeats
(Fig. 5H) were indistinguishable from aged-matched control mice
by routine histology.
Figure 3. Behavior of A02/1 and B05/1 transgenic animals in the bar
cross test. The mean performance values of A02/1 and B05/1 transgenic
5-week-old animals are graphed as the percentage of wild-type animal
activity levels. The performance level in each of the described parameters
(see Materials and Methods) was analyzed by single-factor ANOVA. In
general, B05/1 animals and, to a lesser extent, A02/1 animals displayed
increased spontaneous motor activity (Locomotion Time, Passivity Time,
Cross Attempts, Sniff Up, and Sniff Down) and similar levels of motor
coordination (Turns, Slips, Falls, and Forced Cross) when compared with
wild-type littermate controls (see Results for full description). *p , 0.05;
**p , 0.01; ***p , 0.001.
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Dendritic morphology of SCA1 transgenic mice
Because the shrinkage of the molecular layer was disproportion-
ate to the loss of the Purkinje cell population (see below), the
dendritic morphology of the Purkinje cells was studied by using
immunohistochemical staining for calbindin on 30–50 mm vi-
bratome sections. On P10, P14, P16, and P25 there were no
distinguishable differences in the calbindin immunostaining pat-
terns between B05/1 and control animals (Fig. 6A). At 6 weeks
there were subtle changes in the dendritic staining of Purkinje
cells in B05/1 mice (Fig. 6B). The first discernible alteration was
a decrease in the number of proximal branches of the dendritic
tree on a small number of Purkinje cells. Coupled with this
finding was a loss of dendritic spines on some of the remaining
distal branches. It should be noted that on most Purkinje cells
these alterations were very subtle; however, occasionally Purkinje
cells were observed in which the loss of proximal dendritic
branches and spines was quite dramatic (Fig. 6B, inset).
By 15 weeks, when there was obvious shrinkage of the molec-
ular layer, it was apparent from the calbindin staining that the
shrinkage was attributable to atrophy of Purkinje cells and their
dendritic arbors rather than to loss of the Purkinje cell population
(Fig. 5C,D; see below). There was simplification of the dendritic
array in nearly all Purkinje cells, with loss of spines on many of
the surviving branches. The heterotopic Purkinje cells had atten-
uated dendrites, some of which retained spines that still extended
to the pial surface. Purkinje cells with perikarya that remained at
the interface between the molecular and granular layers fre-
quently had dendritic arrays that ended halfway through the
molecular layer. Calbindin immunoreactivity in the white matter
and deep nuclei was similar in B05/1 transgenic and wild-type
mice at this age.
At 27 weeks, the shrinkage of the molecular layer was more
evident, and the majority of Purkinje cells had a stunted, atrophic
dendritic morphology and smaller perikarya (Fig. 6C,D). Purkinje
cells with more than one primary dendrite were frequent. In
addition, many Purkinje neurons had perikarya within the molec-
ular layer. Dendritic spines were rarely evident. Occasional large,
hypertrophic Purkinje cells were present with luxuriant dendritic
arborization and prominent dendritic spines (Fig. 6D,E). Preser-
vation of normal morphology was more prevalent within lobule X,
but scattered normal cells were seen in other lobules as well. The
processes of many of these cells appeared to occupy a greater area
of molecular layer than normal. The intensity of calbindin immu-
noreactivity was reduced in the white matter but was similar to
that of age-matched controls in the deep nuclear structures.
Axonal torpedoes were not present in B05/1 animals. Animals
examined at 1 year of age had faint, if any, calbindin immunore-
activity in perikarya, axons, and terminal fields despite the pres-
ervation of many Purkinje cells.
One-year-old A02/1 transgenic mice had no evidence of alter-
ations of perikaryal or dendritic morphology, but there were
proximal axonal dilations (torpedoes) in some of the cells (Fig.
6F). Calbindin immunoreactivity in the white matter and deep
nuclei was preserved.
Time course of Purkinje cell loss in SCA1
transgenic mice
Previous analyses of the SCA1 transgenic lines, including B05/1
animals, revealed evidence of Purkinje cell loss (Burright et al.,
1995). To correlate the extent of cell loss with the development of
the neurological abnormalities, we performed quantitative anal-
yses of the Purkinje cell number on cerebellar midline sagittal
sections of wild-type and B05/1 mice at 12 and at 24 weeks of
age. A summary of the results of these studies is presented in
Table 1. At 12 weeks of age, there is evidence of mild (8%) but
statistically insignificant ( p 5 0.1736) Purkinje cell loss in the
cerebellar cortex of a B05/1 animals. By 24 weeks of age there is
an ;32% decrease in the Purkinje cell population, indicating
significant cell loss ( p 5 0.0004). In addition to the extensive cell
loss at 24 weeks, ;21% of the remaining Purkinje cells occupied
heterotopic positions within the molecular layer. The distribution
of Purkinje cell loss and heterotopic positioning was uniform
throughout the cerebellum, with the exception of a relative spar-
ing of cell loss and aberrant positioning within lobule X (data not
shown).
DISCUSSION
The earliest morphological change in mutant SCA1 transgenic
animals (B05/1) is vacuolation of Purkinje cell perikarya at 25 d
of age, before development of any signs of altered neurological
Figure 4. Grid crossings and latency to
the periphery in the open field test by
6-week-old wild-type and B05/1 animals.
Wild-type (n 5 15) and B05/1 transgenic
(n 5 14) animals were scored for total
grid crossings for three 5 min intervals
per day for 6 consecutive days. The mean
number of grid crossings for each scored
interval is shown (A). For both wild-type
and B05/1 animals, the number of grid
crossings in each scored interval de-
creased on a given day. In addition, there
is an overall trend for decreased activity
on each subsequent day. Single-factor
ANOVA indicated no significant differ-
ences between the number of grid cross-
ings made by B05/1 transgenic mice and
wild-type animals except in interval one
on the first day (351 vs 283 crossings,
respectively; p 5 0.0230). The daily mean
latencies for animals to reach the periph-
ery of the open field arena are shown
(B). B05/1 animals reach the periphery
significantly faster than wild-type ani-
mals on the first day of testing. *p , 0.05.
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Figure 5. Cerebellar histology of SCA1 transgenic mice. A, Postnatal day 16 B05/1 transgenic animal with normal cerebellar cortex structure. B, B05/1
animal at P25 with cytoplasmic vacuoles (vac) present in many Purkinje cells. C, B05/1 animal at 8 weeks of age displaying mild gliosis of the molecular
layer and the persistence of cytoplasmic vacuoles. D, B05/1 animal at 12 weeks of age with increased gliosis of the molecular layer. Occasional Purkinje
cells were localized heterotopically (hPC) in the molecular layer. E, B05/1 animal at 15 weeks of age with shrinkage of the molecular and a heterotopic
Purkinje cell. F, B05/1 animal at 24 weeks of age with occasional Purkinje cells with more than one primary dendrite and reduced calbindin
immunoreactivity. G, B05/1 animal at 1 year of age showing Purkinje cell loss and altered morphology. H, One-year-old A02/1 transgenic animal with
normal cerebellar cortical structure and cell morphology. A, B, E, and F are stained immunohistochemically for calbindin and counterstained with
hematoxylin. C, D, G, and H are stained with hematoxylin and eosin. Scale bars: 150 mm in A; 30 mm in B–H. The molecular layer (ml ), Purkinje cell
layer ( pcl ), and granule cell layer ( gcl ) are indicated also. The vacuolar profiles in C, D, G, and H that are not associated with Purkinje cell somata are
vascular lumina dilated by perfusion fixation.
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function. These vacuolar changes are present in at least some
Purkinje cells throughout the life of the animal. Because the
degree of loss of Purkinje cells is minimal throughout much of the
early course of the disease, it is doubtful that the vacuolation is
closely associated with a cell death mechanism.
At the time of decreased motor learning on the rotating rod
apparatus by B05/1 animals, a loss of proximal dendritic branches
and a decrease in the number of dendritic spines were observed in
Purkinje cells of these mice, suggesting that the expression of
mutant ataxin-1 affects the maintenance of dendrites and spines.
It has been suggested that dendritic spines facilitate learning and
memory (Harris and Kater, 1994). Thus, the disruption of Pur-
kinje cell dendrites and spines by the expression of an expanded
SCA1 allele could be the morphological basis for the loss of motor
performance improvement seen in B05/1 mice on the rotating
rod. However, this seems less likely because the Sca1 null mice
that also have a rotating rod performance deficit display no
evidence of Purkinje cell dendritic pathology (A. Matilla, E. D.
Roberson, S. Banfi, J. Morales, D. L. Armstrong, E. N. Burright,
H. T. Orr, D. J. Sweatt, H. Y. Zoghbi, and M. Matzuk, unpub-
lished data).
Although there was little evidence of Purkinje cell loss at the
Figure 6. Immunohistochemical staining of cerebellar sections of SCA1 transgenic mice with calbindin. A, B05/1 animal at P25 showed normal Purkinje
cell morphology. B, B05/1 animal at 6 weeks of age showed a subtle loss in complexity of the proximal aspects of some Purkinje cell dendrites and
occasional Purkinje cells (inset) with extensive reduction in dendritic arborization. C, B05/1 animal at 15 weeks of age with shrinkage of the molecular
layer and many Purkinje cells with atrophic dendritic morphology. Occasional Purkinje cells are located heterotopically in the molecular layer. D, E,
B05/1 animal at 27 weeks of age with increased severity of the changes described in C. In addition, occasional larger hypertrophic Purkinje cells were
apparent. F, A02/1 animal at 1 year of age showed normal Purkinje cell number and dendritic arborization. Some Purkinje cells had proximal axonal
dilations (inset). Scale bars: 30 mm in A–C, E, F; 100 mm in D.
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onset of ataxia in the B05/1 mice (12–15 weeks), there were
significant alterations in Purkinje cell dendritic and perikaryal
morphology as well as evidence of perikaryal heterotopia. These
changes became more widespread and severe as the animals aged.
The intensity of calbindin immunostaining in Purkinje cells and
their processes diminished as the mice aged and by 1 year was
extremely faint despite the persistence of many Purkinje cell
perikarya. The diminution of staining intensity probably reflects
metabolic alterations in the cells related to expression of the
mutant transgene. It is likely that a number of other intrinsic
genes of Purkinje cells have altered expression as a reflection of
the disease process. The use of calbindin immunostaining to
evaluate loss of dendritic spines may be difficult in the later stages
of the disease after the intensity of calbindin staining diminishes
in Purkinje cells. At those later times, however, it is already clear
that there is severe dwindling of the dendritic arbors and that
spine degeneration would be expected. This conclusion is sup-
ported by the observation at early times (Fig. 6B; 6 weeks) when
there is selective loss of branches and spines only in portions of
affected Purkinje cells with complete preservation in other areas
of the same cell. This pattern cannot be simply the result of
diminished expression of calbindin.
A striking feature of B05/1 transgenic mice that followed the
onset of ataxia was the presence of numerous Purkinje cells with
their perikarya heterotopically located in the intermediate levels
of the molecular layer. Histological examination of young animals
revealed no heterotopia during development or in the early stages
of the disease. Therefore, the heterotopia cannot be explained by
abnormal migration of Purkinje cells during development. A
more likely explanation for the occurrence of these malpositioned
cells is based on the appearance of the dendritic changes earlier
in the course of the disease. Purkinje cells have evidence of
simplification of the proximal dendrites with loss of branches and
dendritic spines as early as 6 weeks of age. It is likely that loss of
synaptic input in proximal parts of the dendritic tree, close to the
perikaryon, would make it difficult for the cell to generate an
action potential. A compensatory mechanism to maintain electri-
cal activity in the Purkinje cell might be to retract the nonfunc-
tional denuded dendritic trunk. Because the morphologically pre-
served distal dendrites likely would need to maintain contact with
parallel fibers in the superficial molecular layer, the only way the
shortening of the proximal dendritic trunk can occur is by move-
ment of the perikaryon into the molecular layer with compensa-
tory elongation of the axon.
Several postmortem studies of the cerebellum in patients with
SCA1 have shown structural abnormalities of Purkinje cells as
well as cell loss. Using Golgi techniques and immunohistochem-
ical methods, Ferrer and colleagues (1994) and Koeppen (1991)
have described dendritic simplification with loss of spines, similar
to what we describe here in the B05/1 transgenic mice. It is clear
from autopsy studies of SCA1 patients that morphological alter-
ations antedate cell death in at least some of the Purkinje cells of
these patients. Targeting of the SCA1 mutation to a single cell
type known to be involved in the native disease, the Purkinje cell,
has allowed us to evaluate the relative effects of structural alter-
ations and cellular loss on the development of ataxia in our
transgenic mice.
Although we did not attempt to quantitate the total number of
Purkinje cells in B05/1 animals, the quantitative studies that we
did perform indicate that there is little loss of Purkinje cells at the
onset of ataxia. Comparison of the transgenic B05/1 mice with
another transgenic line, SV4, is particularly informative concern-
ing the role of Purkinje cell loss in the development of ataxia.
Both transgenic lines were generated using the same Purkinje
cell-specific promoter. In the SV4 line, for which the transgene
product was SV40 T-antigen, the Purkinje cells underwent apo-
ptosis within a short period after the onset of transgene expres-
sion (Feddersen et al., 1992). The SV4 mice were evaluated
quantitatively by the same methods used in the present study. The
SV4 mice were examined before and after the onset of ataxia.
The animals did not become ataxic, however, until approximately
two-thirds of Purkinje cells had been lost. Likewise, in pcd mice
in which ataxia is thought to be related to loss of Purkinje cells,
the onset of ataxia does not occur until ;50% of those cells are
lost (Mullen et al., 1976). Therefore, in models of ataxia that
result from death of Purkinje cells, an easily detectable decrease
in the Purkinje cell population is required to induce disease. In
contrast, B05/1 animals that expressed mutant ataxin-1 devel-
oped ataxia at a time when Purkinje cell loss was negligible. This
observation, coupled with the numerous Purkinje cell morpho-
logical abnormalities in B05/1 transgenic animals, clearly indi-
cates that expression of mutant ataxin-1 can lead to cellular
dysfunction sufficient to induce ataxia without causing biologi-
cally significant loss of the affected neuronal population. There-
fore, we conclude that, in the SCA1 transgenic mice, disease is not
caused primarily by cell loss. Rather, loss of Purkinje cells seen at
later stages of disease progression is most likely the result of the
dysfunction induced at an earlier stage.
Animals of the B05/1 SCA1 transgenic line develop a progres-
sive loss of cerebellar function. Results of behavioral tests dem-
onstrate that at an early stage cerebellar impairment appears to
be limited to a subtle motor performance deficit, as assessed by
the accelerating rotating rod apparatus. It should be noted that
the use of this paradigm to assess deficits in motor learning is
controversial because of the difficulty in distinguishing between
deficits in motor learning and impairments in motor perfor-
mance. However, several features of the performance of young
B05/1 animals suggest that their deficits on the rotating rod are
not attributable to a lower performance capability. At 5 weeks of
age the B05/1 animals perform as well as the wild-type littermate
controls on the first day of trials on the rotating rod but have an
impairment only on successive days of trials (see Fig. 2A). This
observation indicates that a training or learning phase might be
required for the deficiency in B05/1 to manifest itself. The
absence of abnormalities in gait and in the bar cross, open field,
and full-speed rotating rod tests also supports the conclusion that
the impairment on the rotating rod is not attributable simply to
an impairment in motor activity, fine motor control, or
coordination.
With increasing age, as the cerebellar impairments of B05/1
mice worsen to reach a stage of severe ataxia, deficiencies in
motor activity and gait become apparent. By 1 year of age when
there is substantial loss of cerebellar function, B05/1 mice are
never able to match the performance of wild-type animals on the
Table 1. Summary of Purkinje cell count experiments
Age
(week) Genotype
Number
of animals
Mean PC
number 6 SEM p value
12 wild-type 3 615 6 16.1
12 B05/1 4 557 6 28.7 0.1736
24 wild-type 3 650 6 17.4
24 B05/1 4 444 6 17.3 0.0004
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rotating rod, even on the first day of trials, and do not demon-
strate any ability to improve their performance with training (see
Fig. 2D,E). Furthermore, 1-year-old B05/1 mice are unable to
perform the behaviors on the bar cross apparatus, typically falling
off immediately on placement on the wide platform. These results
suggest that the cerebellar dysfunction of the B05/1 mice can be
divided into two phases. In the first phase, dysfunction is limited
to an impairment of motor learning. At a later stage, impairment
advances to a point at which motor activity and coordination
become abnormal, and severe ataxia ensues.
Of note is the demonstration that at 5 weeks of age B05/1 mice
exhibit increased levels of spontaneous motor activity on both the
bar cross apparatus and in the open field test (during the first 5
min interval of day 1). A relationship between ataxin-1 expression
and spontaneous motor activity is indicated also by a decrease in
this activity in Sca1 null mice (A. Matilla, E. D. Roberson, S.
Banfi, J. Morales, D. L. Armstrong, E. N. Burright, H. T. Orr, D.
J. Sweatt, H. Y. Zoghbi, and M. Matzuk, unpublished data).
Because transgene expression in the B05/1 mice was limited to
Purkinje cells of the cerebellar cortex, it can be concluded that the
increase in spontaneous motor activity seen in B05/1 animals is
attributable to a function of ataxin-1 within Purkinje cells.
Finally, the presence of a motor performance deficit (acceler-
ating rotating rod) and divergent spontaneous exploratory behav-
iors (open field test) in young B05/1 SCA1 transgenic mice and in
Sca1 2/2 mice (A. Matilla, E. D. Roberson, S. Banfi, J. Morales,
D. L. Armstrong, E. N. Burright, H. T. Orr, D. J. Sweatt, H. Y.
Zoghbi, and M. Matzuk, unpublished data) is intriguing. Alter-
ation of these behaviors in young B05/1 mice indicates that
proper ataxin-1 expression by cerebellar Purkinje cells is required
for normal motor performance and exploratory behavior. That
perturbations in these behaviors are found in young B05/1 and
Sca1 2/2 mice suggests that a component of the initial alteration
in neurological behavior seen with the expression of an expanded
allele of SCA1 is caused by a compromise in ataxin-1 function,
e.g., by a loss of function or dominant negative mutation. In this
regard, it should be noted that a region that promotes the self-
association of ataxin-1 and its interaction with other proteins has
been identified (Burright et al., 1997). Clearly, the availability of
mice with a null mutation of Sca1 and of transgenic mice with
Purkinje cell-specific expression of SCA1 alleles offers valuable
resources for the elucidation of ataxin-1 function in complex
neurological behaviors at the cellular level.
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